Creutzfeldt-Jakob disease and the eye. II. Ophthalmic and neuro-ophthalmic features

Eye (Basingstoke)

Volumn 14, Issue 3, 2000, Pages 291-301

  Lueck, C J ^a   McIlwaine, G G ^a,b   Zeidler, M ^a  

^a WESTERN GENERAL HOSPITAL   (United Kingdom)

^b PRINCESS ALEXANDRA EYE PAVILION   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BINOCULAR CONVERGENCE; BLEPHAROSPASM; CEREBRAL BLINDNESS; CLINICAL FEATURE; COLOR BLINDNESS; COLOR VISION DEFECT; CREUTZFELDT JAKOB DISEASE; DIPLOPIA; DYSLEXIA; EYE; EYE FUNDUS; HOMONYMOUS HEMIANOPIA; HUMAN; INTERNUCLEAR OPHTHALMOPLEGIA; NEUROOPHTHALMOLOGY; NYSTAGMUS; OPHTHALMOPLEGIA; OPTOKINETIC NYSTAGMUS; OSCILLOPSIA; PRION DISEASE; PTOSIS; PUPIL DISEASE; REVIEW; SACCADIC EYE MOVEMENT; SMOOTH PURSUIT EYE MOVEMENT; SYMPTOMATOLOGY; VESTIBULOOCULAR REFLEX; VISUAL DISORDER; VISUAL FIELD DEFECT; VISUAL HALLUCINATION; VISUAL IMPAIRMENT;

EID: 0033926960     PISSN: 0950222X     EISSN: 14765454     Source Type: Journal    
DOI: 10.1038/eye.2000.76     Document Type: Review

References (244)

1. Brown P, Cathala F, Castaigne P, Gajdusek DC. CreutzfeldtJakob disease: clinical analysis of a consecutive series of 230 neuropathologically verified cases. Ann Neurol 1986; 20: 597-602.
2. Brown P, Gibbs CI, Rodgers-Johnson P, Human spongiform encephalopathy: the National Institutes of Health series of 300 cases of experimentally transmitted disease. Ann Neurol 1994; 35: 513-29.
3. Leuck Q, McIlwaine GG, Zeidler M. Creutzfeldt-Jakob disease and the eye. I. Background and patient management. Eye 2000; 14: 263-90.
4. Brown P, Cathala F, Sadowsky D, Gajdusek DC. Creutzfeldt-Jakob disease in France. II. Clinical characteristics of 124 consecutive verified cases during the decade 1968-1977. Ann Neurol 1979; 6: 430-7.
5. Siedler H, Malamud N. Creutzfeldt-Jakob's disease: clinicopathologic report of 15 cases and review of the literature (with special reference to a related disorder designated as subacute spongiform encephalopathy). J Neuropathol Exp Neurol 1983; 27: 381-402.
6. Tsuji S, Kuroiwa Y. Creutzfeldt-Jakob disease in Japan. Neurology 1983; 33: 1503-6.
7. Will RG. The epidemiology of Creutzfeldt-Jakob disease [thesis]. 1984. University of Cambridge.
8. Will RG, Matthews WB. A retrospective study of Creutzfeldt-Jakob disease in England and Wales 1970-79. I. Clinical features. J Neurol Neurosurg Psychiatry 1984; 47: 134-40.
9. Brown P, Goldfarb LG, Kovanen J, Phenotypic characteristics of familial Creutzfeldt-Jakob disease associated with the codon 178Asn PRNP mutation. Ann Neurol 1992; 31: 282-5.
10. Maertens P, Quindlen EA. Clinical manifestations. In: Bastian Fa, editor. Creutzfeldt-Jakob disease and other transmissible spongiform encephalopathies. St Louis: Mosby Year Book, 1991: 131-52.
11. De Silva R. Human spongiform encephalopathy. In: Baker HF, Ridley RM, editors. Methods in molecular medicine: prion diseases. Totowa, NJ: Humana Press, 1996: 15-33.
12. Kropp S, Schulz-Schaeffer WI, Finkenstaedt M, The Heidenhain variant of Creutzfeldt-Jakob disease. Arch Neurol 1999; 56: 55-61.
13. Nevin S. On some aspects of cerebral degeneration in later life. Proc R Soc Lond B 1967; 60: 517-26.
14. Roos R, Gajdusek DC, Gibbs Q. The clinical characteristics of transmissible Creutzfeldt-Jakob disease. Brain 1973; 96: 1-20.
15. Cathala F, Brown P, Castaigne P, Gajdusek DC. La maladie de Creutzfeldt-Jakob en France continentale: etude retrospective de 1968 11 1977. Rev Neurol (Paris) 1979; 135: 439-54.
16. Masullo C, Pocchiari M, Neri G, A retrospective study of Creutzfeldt-Jakob disease in Italy (1972-1986). Eur J Epidemiol 1988; 4: 482-7.
17. Johnston RT, Gibbs q. Creutzfeldt-Jakob disease and related transmissible spongiform encephalopathies. N Engl J Med 1998; 339: 1994-2004.
18. Brown P, Preece MA, Will RG. 'Friendly fire' in medicine: hormones, homografts, and Creutzfeldt-Jakob disease. Lancet 1992; 340: 24-7.
19. Billette De Villemeur T, Deslys J-P, Pradel A, Creutzfeldt-Jakob disease from contaminated growth hormone extracts in France. Neurology 1996; 47: 690-5.
20. Lang QG, Heckmann JG, Neundorfer B. Creutzfeldt-Jakob disease via dural and corneal transplants. J Neural Sci 1998; 160: 128-39.
21. Zlotnik I, Grant DP, Dayan AD, Earl Q. Transmission of Creutzfeldt-Jakob disease from man to squirrel monkey. Lancet 1974; 11: 435-8.
22. Heidenhain A. Klinische und anatomische Untersuchungen tiber eine eigenartige organische Erkrankung des Zentralnervensystems in Praesenium. Z Ges Neurol Psych 1928; 118: 49-114.
23. Meyer A, Leigh D, Bagg CE. A rare presenile dementia associated with cortical blindness (Heidenhain's syndrome). J Neurol Neurosurg Psychiatry 1954; 17: 129-33.
24. Silberman J, Cravioto H, Feigin I. Cortico-striatal degeneration of the Creutzfeldt-Jakob type. Neuropathol Exp Neurol 1961; 20: 105-18.
25. Butler HM, Williams GH, McCormack LJ. Clinical observations on seven pathologically proved cases of Creutzfeldt-Jakob disease. Trans Am Neurol Assoc 1963; 88: 30-2.
26. Amyot R, Gauthier e. Sur la maladie de Creutzfeld-Jakob: deux observations anatomo-cliniques. Conception uniciste. Rev Neurol (Paris) 1964; 110: 473-88.
27. Boudouresques J, Toga M, Roger J, Encephalopathie presenile d'evolution subaigue type Heidenhain. Rev Neurol (Paris) 1968; 119: 468-76.
28. Schlote W. Subakute prasenile spongiforme Encephalopathie mit occipitalem Schwerpunkt und Rindenblindheit (Heidenhain-Syndrom). Arch Psych Nervenk 1970; 2l3: 345-69.
29. Hopf HC, Althaus HH, Sabuneu S. Typ Heidenhain' der subakuten spongiosen Encephalopathie (SSE) Creutzfeldt-Jakob. Z Neurol 1974; 206: 149-56.
30. Bosch PL, Vass K. Subakute spongiose Encephalopathie vom typ Heidenhain. Nervenarzt 1975; 46: 160-2.
31. Iwanowski L, Kunicka J. Przypadek choroby JakobaCreutzfeldta 0 rzadko spotykanej topografii zmian (tzw. zespolu Heidenhaina). Neurologiai Neurochirurgia Polska 1977; 11: 247-50.
32. Galvez S, Dorr-Zegers O, Cartier I. Zur Klinik, Neuropathologie und Pathogenese der Creutzfeldt-Jakobschen Krankheit anhand von 40 gesicherten Fallen. Nervenarzt 1982; 53: l32-40.
33. Piccardo A, Tabaton M, Meneghini S, Leonardi A. Forma corticocerebellare della malattia di Creutzfeldt-Jakob: studio anotomo-clinico. Pathologica 1983; 75: 577-81.
34. Jibiki I, Fukushima T, Kobayashi K, Utility of 123I_IMP SPECT brain scans for the early detection of site-specific abnormalities in Creutzfeldt-Jakob disease (Heidenhain type): a case study. Neuropsychobiology 1994; 29: 117-9.
35. Kitagawa Y, Gotoh F, Koto A, Creutzfeldt-Jakob disease: a case with extensive white matter degeneration and optic atrophy. J Neurol 1983; 229: 97-101.
36. Ferrer I, Saracibar N, Gonzalez G. Encefalopatia espongiforme y degneracion multisistemica. Neurologia 1991; 6: 29-33.
37. Uchino A, Yoshinaga M, Shiokawa O, Hata H, Ohno M Serial MR imaging in Creutzfeldt-Jakob disease. Neuroradiology 1991; 33: 364-7.
38. Yoshikawa H, Fukuda K, Nakamura Y, A case of Creutzfeldt-Jakob disease associated with myocarditis. Kokyo to Junkan-Respiration and Circulation 1991; 39: 389-93.
39. Hayashi R, Hanyu N, Kuwabara T, Moriyama S. Serial computed tomographic and electroencephalographic studies in Creutzfeldt-Jakob disease. Acta Neurol Scand 1992; 85: 161-5.
40. Sato Y, Chiba S, Miyagishi T. A case of panencephalopathic type of Creutzfeldt-Jakob disease with retinal involvement. Hokkaido Igaku Zasshi-Hokkaido. J Med Sci 1992; 67: 703-11.
41. Tarnai Y, Kojima H, Kitajima R, Demonstration of the transmissible agent in tissue from a pregnant woman with Creutzfeldt-Jakob disease. N Engl J Med 1992; 327: 649.
42. Pocchiari M, Salvatore M, Cutruzzola F, A new point mutation of the prion protein gene in Creutzfeldt-Jakob disease. Ann Neurol 1993; 34: 802-7.
43. Weber T, Tumani H, Holdorff B, Transmission of Creutzfeldt-Jakob disease by handling of dura mater. Lancet 1993; 341: 123-4.
44. Iwasaki Y, Ikeda K, Tagaya N, Kinoshita M. Magnetic resonance imaging and neuropathological findings in two patients with Creutzfeldt-Jakob disease. J Neurol Sci 1994; 126: 228-31.
45. Shimizu T, Tanaka K, Tanahashi N, Fukuuchi Y, Kitamoto T. Creutzfeldt-Jakob disease with a point mutation at codon 232 of prion protein: a case report. Rinsho Shinkeigaku-Clin Neurol 1994; 24: 590-2.
46. Marchiori PE, Yasuda N, Azevedo HC, Creutzfeldt-Jakob disease: a survey of 14 patients. Arquivos de Neuro-Psiquiatria 1996; 54: 577-83.
47. Itoh Y, Amano T, Shimizu T, Hashimoto J, Kubo A, Fukuuchi Y. Single-photon emission computed tomography image of benzodiazepine receptors in a patient with Creutzfeldt-Jakob disease. Intern Med 1998; 37: 896-900.
48. Radbauer C, Hainfellner JA, Gaudernak T, Deecke L, Budka H. Creutzfeldt-Jakob-Krankheit bei einem DuraTransplantat-Empfanger: Erstbeobachtung in Osterreich. Wien Klin Wochenschr 1998; 110: 496-500.
49. Hsieh MJ, Wang PY, Chia LG, Kao CH, Wen Me. Creutzfeldt-Jakob disease: clinical analysis of eight cases. Chung Hua i Hsueh Tsa Chih-Chinese Med J 1996; 57: 284-8.
50. Lundberg PO. Creutzfeldt-Jakob disease in Sweden. J Neurol Neurosurg Psychiatry 1998; 65: 836-41.
51. Hirano A, Ghatak NR, Johnson AB, Partnow MJ, Gomori AJ. Argentophilic plaques in Creutzfeldt-Jakob disease. Arch Neurol 1972; 26: 530-42.
52. Brown P, Cervenakova L, McShane L, Creutzfeldt-Jakob disease in a husband and wife. Neurology 1998; 50: 684-8.
53. Goto K, Umezaki H, Suetsugu M. Electroencephalographic and clinicopathological studies on Creutzfeldt-Jakob syndrome. J Neurol Neurosurg Psychiatry 1976; 39: 931-40.
54. Okiyama R, Tsuchiya K, Furukawa T, Tsukagoshi H, Kosaka K. An autopsy case of panencephalopathic type of Creutzfeldt-Jakob disease: an early clinical sign documented by magnetic resonance imaging. Rinsho Shinkeigaku-Clin Neurol 1989; 29: 1048-51.
55. Taratuto AL, Piccardo P, Leiguarda R, Creutzfeldt-Jakob disease: report of 10 neuropathologicallyverified cases in Argentina. Medicina (Buenos Aires) 1989; 49: 293-303.
56. Babincova O, Siblova O, Selinger P. Pripad CreutzfeldtovyJakobovy nemoci s dominujicimi ocnimi priznaky. Ceskoslovenska Oftalmologie 1994; 50: 371-6.
57. Hudson AJ, Farrell MA, Kalnins R, Kaufmann JCE. Gerstmann-Straussler-Scheinker disease with coincidental familial onset. Ann Neurol 1983; 14: 670-8.
58. Schlote W, Boellaard JW, Schumm F, Stohr M. Gerstrnann-Straussler-Scheinker's disease. Electronmicroscopic observations on a brain biopsy. Acta Neuropathol 1980; 52: 203-11.
59. Nelson JR, Leffman H. The human diffusely projecting system: evoked potentials and interactions. Arch Neurol 1963; 8: 544-56.
60. Nevin S, McMenemey WH, Behrman S, Jones DP. Subacute spongiform encephalopathy: a subacute form of encephalopathy attributable to vascular dysfunction (spongiform cerebral atrophy). Brain 1960; 83: 519.
61. Morice J, Turpin JC, Pluot M, Level G. Encephalopathie spongiforme subaigue et maladie de Creutzfeldt-Jakob: a propos d'un cas. Rev Neurol (Paris) 1975; 131: 573-82.
62. Brown P, Cathala F. Creutzfeldt-Jakob disease in France. I. Retrospective study of the Paris area during the ten-year period 1968-1977. Ann Neurol 1979; 5: 189-92.
63. Falcone S, Quencer RM, Bowen B, Bruce JH, Naidich TP. Creutzfeldt-Jakob disease: focal symmetrical cortical involvement demonstrated by MR imaging. Am J Neuroradiol 1992; l3: 403-6.
64. Finkenstaedt M, Szudra A, Zerr I, MR imaging of Creutzfeldt-Jakob disease. Radiology 1996; 199: 793-8.
65. Aoki T, Kobayashi K, Jibiki I, An autopsied case of Creutzfeldt-Jakob disease with the lateral geniculate body lesion showing antagonizing correlation between periodic synchronous discharges and photically induced giant evoked responses. Psychiatry Clin Neurosci 1998; 52: 333-7.
66. Purvin V, Bonnin J, Goodman J. Palinopsia as a presenting manifestation of Creutzfeldt-Jakob disease. J Clin Neuroophthalmol 1989; 9: 242-6.
67. Grant MP, Cohen M, Petersen RB, Abnormal eye movements in Creutzfeldt-Jakob disease. Ann Neurol 1993; 34: 192-7.
68. Vargas ME, Kupersmith MJ, Savino PJ, Petito F, Frohman LP, Warren FA. Homonymous field defect as the first manifestation of Creutzfeldt-Jakob disease. Am J Ophthalmol 1995; 119: 497-504.
69. Rauber M, Knaflic D, Mester U. Sehverschlechterung als Erstymptom einer Creutzfeld-Jakob-Erkrankung. Klin Monatsbl Augenheilkd 1997; 211: A10-A13.
70. Lesser RL, Albert DM, Bobowick AR, O'Brien FH. Creutzfeldt-Jakob disease and optic atrophy. Am J Ophthalmol 1979; 87: 317-21.
71. Fisher CM. The clinical picture in Creutzfeldt-Jakob disease. Trans Am Neurol Assoc 1960; 85: 147-50.
72. Wolpow ER, Richardson EP. Case records of the Massachusetts General Hospital. Case 45-1980. N Engl J Med 1980; 303: 1162-71.
73. Shih WI, Markesbery WR, Clark DB, Iodine-123 HIPDM brain imaging findings in subacute spongiform encephalopathy (Creutzfeldt-Jakob disease). J Nucl Med 1987; 28: 1484-7.
74. Aguglia U, Oliveri RL, Gambardella A, Zappia M, Quattrone A. Combined neurophysiological studies in Creutzfeldt-Jakob disease: a case report. Clin Electroencephalogr 1989; 20: 103-10.
75. Aguglia U, Oliveri RL, Gambardella A, Quattrone A. Functional integrity of benzodiazepine receptors of the geniculo-striate visual pathways in Creutzfeldt-Jakob disease. J NeuroI 1993; 240: 25-7.
76. Mizutani T, Okumura A, Oda M, Shiraki H. Panencephalopathic type of Creutzfeldt-Jakob disease: primary involvement of the cerebral white matter. J Neurol Neurosurg Psychiatry 1981; 44: 103-15.
77. Kruger H, Meesmann C Rohrbach E, Muller I, Mertens HG. Panencephalopathic type of Creutzfeldt-Jakob disease with primary extensive involvement of white matter. Eur Neurol 1990; 30: 115-9.
78. Nicholl D, Windl O, De Silva R, Inherited Creutfeldt-Jakob disease in a British family associated with a novel 144 base pair insertion of the prion protein gene. J Neurol Neurosurg Psychiatry 1995; 58: 65-9.
79. Croxson M, Brown P, Synek B, A new case of Creutzfeldt-Jakob disease associated with human growth hormone therapy in New Zealand. Neurology 1988; 38: 1128-30.
80. Takayama S, Hatsuda N, Matsumura K, Nakasu S, Handa J. Creutzfeldt-Jakob disease transmitted by cadaveric dural graft: a case report. No Shinkei Geka-Neurol Surg 1993; 21: 167-70.
81. Lane KL, Brown P, Howell DN, Creutzfeldt-Jakob disease in a pregnant woman with an implanted dura mater graft. Neurosurgery 1994; 34: 737-40.
82. Martinez-Lage JF, Poza M, Sola J, Accidental transmission of Creutzfeldt-Jakob disease by dural cadaveric grafts. J Neurol Neurosurg Psychiatry 1994; 57: 1091-4.
83. Takashima S, Tateishi I, Taguchi Y, Creutzfeldt-Jakob disease with a widespread presence of kuru-type plaques after cadaveric dural graft replacement: an autopsy case [abstract]. Rinsho Shinkeigaku-Clin NeuroI 1997; 37: 824-8.
84. Yamada M, Itoh Y, Suematsu N, Matsushita M, Otomo E. Panencephalopathic type of Creutzfeldt-Jakob disease associated with cadaveric dura mater graft. J Neurol Neurosurg Psychiatry 1997; 63: 524-7.
85. Schumm F, Boellard JW, Schlote W, StOhr M. Morbus Gerstmann-Straussler-Scheinker. Familie Sch.-Ein Bericht uber drei Kranke. Arch Psych Nervenk 1981; 230: 179-96.
86. Jellinger K, Heiss W-D, Deisenhammer E. The ataxic (cerebellar) form of Creutzfeldt-Jakob disease. J Neurol 1974; 207: 289-305.
87. Tange RA, Troost D, Limburg M. Progressive fatal dementia (Creutzfeldt-Jakob disease) in a patient who received homograft tissue for tympanic membrane closure. Eur Arch Oto-Rhino-Laryngol 1990; 247: 199-201.
88. Esmonde T, Lueck CJ, Symon L, Duchen LW, Will RG. Creutzfeldt-Jakob disease and lyophilised dura mater grafts: report of two cases. J Neurol Neurosurg Psychiatry 1993; 56: 999-1000.
89. Bohnert B, Noetzel H. Beitrag zur familiaren spongiosen glio-neuralen Dystrophie. Arch Psych Nervenk 1974; 218: 353.
90. Urbach H, Klisch J, Wolf HK, Brechtelsbauer D, Gass S, Solymosi I. MRI in sporadic Creutzfeldt-Jakob disease: correlation with clinical and neuropathological data. Neuroradiology 1998; 40: 65-70.
91. Grunwald F, Pohl C Bender H, 18F_ fluorodeoxyglucose-PET and 99mTc-bicisate-SPECT in Creutzfeldt-Jakob disease. Ann Nucl Med 1996; 10: 131-4.
92. Young GR, Fletcher NA, Zeidler M, Estibeiro KL, Ironside JW. Creutzfeldt-Jakob disease in a beef farmer. Lancet 1996; 348: 610-1.
93. Hauser-Dumur F, Radvanyi MF. Evolution electroencephalographique de deux cas de syndrome de Creutzfeldt-Jakob tardifs. Rev Neurol (Paris) 1969; 121: 241-4.
94. Kirschbaum WR. Jakob-Creutzfeldt disease. New York: American Elsevier, 1968.
95. Lee RG, Blair RDG. Evolution of EEG and visual evoked response changes in Jakob-Creutzfeldt disease. EEG Clin Neurophysiol 1973; 35: 133-42.
96. Park TS, Kleinman GM, Richardson EP. Creutzfeldt-Jakob disease with extensive degeneration of white matter. Acta Neuropathol (Berlin) 1980; 52: 239-42.
97. Pinto Junior LR, Lancelloti CL, Nozuka AP, Andivar AP, Anvito WL. Forma de Heidenhain da doenca de Creutzfeldt-Jakob: relato de urn caso. Arquivos de NeuroPsiquiatria 1986; 44: 60-6.
98. Tsutsui J, Kawashima S, Kajikawa I, Shirabe T, Terao A. Electrophysiological and pathological studies on Creutzfeldt-Jakob disease with retinal involvement. Doc Ophthalmol 1986; 63: 13-21.
99. Holthoff VA, Sandmann J, Pawlik G, Schroder R, Heiss WD. Positron emission tomography in Creutzfeldt-Jakob disease. Arch Neurol 1990; 47: 1035-8.
100. Victoroff J, Ross GW, Benson DF, Verity MA, Vinters HV. Posterior cortical atrophy: neuropathologic correlations. Arch Neurol 1994; 51: 269-74.
101. Miller DA, Vitti RA, Maslack MM. The role of 99mTc_ HMPAO SPECT in the diagnosis of Creutzfeldt-Jacob disease. Am J Neuroradiol 1998; 19: 454-5.
102. Brown P, Goldfarb LG, McCombie WR, Atypical Creutzfeldt-Jakob disease in an American family with an insert mutation in the PRNP amyloid precursor gene. Neurology 1992; 42: 422-7.
103. Goldfarb LG, Brown P, Little BW, A new (two repeat) octapeptide coding insert mutation in Creutzfeldt-Jakob disease. Neurology 1993; 43: 2392-4.
104. Chapman J, Brown P, Goldfarb LG, Arlazoroff A, Gajdusek DC, Korczyn AD. Clinical heterogeneity and unusual presentations of Creutzfeldt-Jakob disease in Jewish patients with the PRNP codon 200 mutation. J Neurol Neurosurg Psychiatry 1993; 56: 1109-12.
105. Yee AS, Simon JH, Anderson CA, Sze C-I, Filley CM. Diffusion-weighted MRI of right-hemisphere dysfunction in Creutzfeldt-Jakob disease. Neurology 1999; 52: 1514.
106. Rizzo M, Corbett JJ, Thompson HS. Is applanation tonometry a risk factor for transmission of Creutzfeldt-Jakob disease? Arch Ophthalmol 1987; 105: 314.
107. May WW. Creutzfeldt-Jakob disease 1 Survey of the literature and clinical diagnosis. Acta Neurol Scand 1968; 44: 1-32.
108. Lafon R, Labauge R, van Bogaert L, Castan P. Sur l'unite histopathologique des encephalopathies subaigues (types Creutzfeldt-Jakob, Heidenhain et Nevin). Rev Neurol (Paris) 1965; 112: 201-27.
109. Matthews WB, Hyman NM, Bannister R, Trevor Hughes J, Pyke DA, Milne MD. Two neurological cases. Demonstration at the Royal College of Physicians of London. BMJ 1979; 1: 727-32.
110. Sitwell L, Lach B, Atack E, Atack D, Izukawa D. Creutzfeldt-Jakob disease in histopathology technicians. N Engl J Med 1988; 318: 854.
111. Lee KE, Loh NK, Tan AK, Tija HT. Creutzfeldt-Jakob disease presenting with visual blurring, diplopia and visual loss: Heidenhain's variant. Ann Acad Med Singapore 1998; 27: 85.
112. Schneck SA, Hedley-White ET. Case records of the Massachusetts General Hospital. Case 49-1983. N Engl J Med 1983; 309: 1440-9.
113. Levy SR, Chiappa KH, Burke CJ, Young RR. Early evolution and incidence of electroencephalographic abnormalities in Creutzfeldt-Jakob disease. J Clin Neurophysiol 1986; 3: 1-21.
114. Kirk A, Ang LC. Unilateral Creutzfeldt-Jakob disease presenting as rapidly progressive aphasia. Can J Neurol Sci 1994; 21: 350-2.
115. Christensen E, Brun A. Subacute spongiform encephalopathy: spongiform cerebral atrophy. Neurology 1963; 13: 455-63.
116. Garzuly F, Jellinger K, Pilz P. Subakute spongiiise Encephalopathie (Jakob-Creutzfeldt-Syndrom): klinischmorphologische Analyse von 9 Fiillen. Arch Psych Nervenk 1971; 214: 207-27.
117. Elliott F, Gardner-Thorpe C, Barwick DD, Foster JB. Jakob-Creutzfe1dt disease: modification of clinical and electroencephalographic activity with methylphenidate and diazepam. J Neurol Neurosurg Psychiatry 1974; 37: 879-87.
118. Stafen W, Trinka E, Iglseder B, Pilz P, Homann N, Ladurner G. Clinical and diagnostic findings in a patient with Creutzfeldt-Jakob disease (type Heidenhain). J Neuroimaging 1997; 7: 50-4.
119. Adam J, Crow TJ, Duchen LW, Scaravilli F, Spokes E. Familial cerebral amyloidosis and spongiform encephalopathy. J Neurol Neurosurg Psychiatry 1982; 45: 37-45.
120. Collinge J, Palmer MS, Campbell T, Sidle KCL, Carroll D, Harding A. Inherited prion disease (PrP lysine 200) in Britain: two case reports. BMJ 1993; 306: 301-2.
121. Masullo C, Pocchiari M, Macchi G, Alema G, Piazza G, Panzera MA. Transmission of Creutzfeldt-Jakob disease by dural cadaveric graft. J Neurosurg 1989; 71: 954-5.
122. Collinge J, Brown J, Hardy J, Inherited prion disease with 144 base pair gene insertion. 2. Clinical and pathological features. Brain 1992; 115: 687-710.
123. Kreindler A, Vuia O, Marcutiu V, Alexianu M. Die subakute Encephalopathie Creutzfeldt-Jakob, eine abiotrophische Degeneration des Praseniums. Dtsch Z Nervenheilkd 1968; 193: 351-69.
124. Capon A, Colin F, Deltenre P, Hubert JP, Flament-Durand J. Etude electrophysiologique de deux cas de maladie de Creutzfeldt-Jakob. Rev Encephalogr Neurophysiol Clin 1976; 6: 130-6.
125. Paty J, Bonnaud E, Latinville D, Correlations electrophysiologiques, cliniques et anatomiques dans un cas de maladie de Creutzfeldt-Jakob (forme de Heidenhain). Rev Neurol (Paris) 1978; 134: 223-31.
126. Jibiki I, Fukushima T, Kobayashi K, Aoki T, Yamaguchi N. Antagonizing correlation between periodic synchronous discharges and photically induced giant evoked responses in Creutzfeldt-Jakob disease (Heidenhain type): a case study. Psychiatry Clin Neurosci 1995; 49: 87-90.
127. Bortone E, Bettoni L, Giorgi C, Terzano MG, Trabattoni GR, Mancia D. Reliability of EEG in the diagnosis of Creutzfeldt-Jakob disease. EEG Clin Neurophysiol 1994; 90: 323-30.
128. De Silva RN. A correlative study of the clinical, pathological and molecular biological features of Creutzfeldt-Jakob disease [thesis]. 1998. University of Edinburgh.
129. Blisard KS, Davis LE, Harrington MG, Lovell JK, Kornfield M, Berger ML. Pre-mortem diagnosis of Creutzfeldt-Jakob disease by detection of abnormal cerebrospinal fluid proteins. J Neurol Sci 1990; 99: 75-81.
130. Onofrj M, Fulgente T, Gambi D, Macchi G. Early MRI findings in Creutzfeldt-Jakob disease. J Neurol 1993; 240: 423-6.
131. Zeidler M, Stewart GE, Barraclough CR, New variant Creutzfeldt-Jakob disease: neurological features and diagnostic tests. Lancet 1997; 350: 903-7.
132. Aguglia U, Farnarier G, Tinuper P, Rey M, Gomez M, Quattrone A. Subacute spongiform encephalopathy with periodic paroxysmal activities: clinical evolution and serial EEG findings in 20 cases. Clin Electroencephalogr 1987; 18: 147-58.
133. Jones DP, Nevin S. Rapidly progressive cerebral degeneration (subacute vascular encephalopathy) with mental disorder, focal disturbances, and myoclonic epilepsy. J Neurol Neurosurg Psychiatry 1954; 17: 148-59.
134. Roth AM, Keltner JL, Ellis WG, Martins-Green M. Virussimulating structures in the optic nerve head in Creutzfeldt-Jakob disease. Am J Ophthalmol 1979; 87: 827-33.
135. Khurana RK, Garcia JH. Autonomic dysfunction in subacute spongiform encephalopathy. Arch Neurol 1981; 38: 114-7.
136. Heye N, Farahati J, Heinz A, Buttner T, Przuntek H, Reiners C. Topodiagnostik der Creutzfeldt-Jakobschen Krankheit durch HMPAO-SPECT. Nuklearmedizin 1993; 32: 57-9.
137. Kazukawa S, Nakamura I, Endo M, Hori A, Inao G. Serial polysornnograrns in Creutzfeldt-Jakob disease. Jpn J Psych Neurol 1987; 41: 651-61.
138. Pietrini W. Creutzfeldt-Jakob disease presenting as Wernicke-Korsakoff syndrome. J Neurol Sci 1992; 108: 149-53.
139. Di Rocco A, Molinari S, Stollman AL, Decker A, Yahr MD. MRI abnormalities in Creutzfeldt-Jakob disease. Neuroradiology 1993; 35: 584-5.
140. Heinz A, Schmidt LG, Winterer G, Gerhard I, Przuntek H. Optische und taktile Halluzinose als klinischer Beginn einer Creutzfeldt-Jakob-Erkrankung. Nervenarzt 1995; 66: 712-6.
141. Kujat C, Hagen T, Feiden W. Creutzfeldt-Jakob-Krankheit. Welche Rolle spielt die MR-Tomographie? Radiologe 1995; 35: 834-7.
142. Sugita Y, Matsumine H, Wakiya M, A 64-year-old woman with progressive gait disturbance and dementia for one year (clinical conference) [in Japanese]. No to ShinkeiBrain Nerve 1998; 50: 861-70.
143. Monreal J, Collins GH, Masters CL, Creutzfeldt-Jakob disease in an adolescent. J Neurol Sci 1981; 52: 341-50.
144. Mitrova E. A case of Creutzfeldt-Jakob disease related to familial retinitis pigmentosa patients. Eur J Epidemiol 1988; 4: 55-9.
145. Pearl GS, Anderson RE. Creutzfeldt-Jakob disease: high caudate signal on magnetic resonance imaging. South Med J 1989; 82: 1177-80.
146. Kawata A, Suga M, Oda M, Hayashi H, Tanabe H. Creutzfeldt-Jakob disease with congophilic kuru plaques: CT and pathological findings of the cerebral white matter. J Neurol Neurosurg Psychiatry 1992; 55: 849-51.
147. Davies PTG, Jahfar S, Ferguson IT, Windl O. Creutzfeldt-Jakob disease in an individual occupationally exposed to BSE. Lancet 1993; 342: 680.
148. Berciano J, Pascual J, Polo JM, Combarros O, Figols J, Diez C. Ataxic type of Creutzfeldt-Jakob disease with disproportionate enlargement of the fourth ventricle: a serial CT study. J Neurol Neurosurg Psychiatry 1997; 62: 295-7.
149. Hill AF, Butterworth RJ, Joiner S, Investigation of variant Creutzfeldt-Jakob disease and other human prion diseases with tonsil biopsy samples. Lancet 1999; 353: 183-9.
150. Bateman D, Hilton D, Love S, Zeidler M, Beck L Collinge J. Sporadic Creutzfeldt-Jakob disease in an 18-year-old in the UK. Lancet 1995; 346: 1155-6.
151. Zeidler M, Johnstone EE, Bamber RWK, New variant Creutzfeldt-Jakob disease: psychiatric features. Lancet 1997; 350: 908-10.
152. Prichard L Thadani V, Kalb R, Manuelidis E, Hadler J. Rapidly progressive dementia in a patient who received a cadaveric dura mater graft. MMWR 1987; 36: 49-55.
153. Thadani V, Penar PL, Partington L Creutzfeldt-Jakob disease probably acquired from a cadaveric dura mater graft: case report. J Neurosurg 1988; 69: 766-9.
154. Martinez-Lage JF, Sola J, Poza M, Esteban JA. Pediatric Creutzfeldt-Jakob disease: probable transmission by a dural graft. Childs Nerv Syst 1993; 9: 239-42.
155. Macario ME, Vaisman M, Buescu A, Moura Neto V, Auaujo HMM, Chagas C. Pituitary growth hormone and Creutzfeldt-Jakob disease. BMJ 1991; 302: 1149.
156. Bertoni JM, Label LS, Sackelleres JE, Hicks SP. Supranuclear gaze palsy in familial Creutzfeldt-Jakob disease. Arch Neurol 1983; 40: 618-22.
157. Mastrianni JA, Iannicola E, Myers RM, DeArmond S, Prusiner SB. Mutation of the prion protein gene at codon 208 in familial Creutzfeldt-Jakob disease. Neurology 1996; 47: 1305-12.
158. Nochlin D, Sumi SM, Bird TD, Familial dementia with PrP-positive amyloid plaques: a variant of Gerstmann-Straussler syndrome. Neurology 1989; 39: 910-8.
159. Manetto V, Medori R, Cortelli P, Fatal familial insomnia: clinical and pathologic study of five new cases. Neurology 1992; 42: 312-9.
160. Petersen RB, Tabaton M, Berg L, Analysis of the prion protein gene in thalamic dementia. Neurology 1992; 42: 1859-63.
161. Nagayama M, Shinohara Y, Furukawa H, Kitamoto T. Fatal familial insomnia with a mutation at codon 178 of the prion protein gene: first report from Japan. Neurology 1996; 47: 1313-6.
162. Campbell TA, Palmer MS, Will RG, Gibb WRG, Luthert PJ, Collinge J. A prion disease with a novel 96-base pair insertional mutation in the prion protein gene. Neurology 1996; 46: 761-6.
163. Chazot G, Broussolle E, Lapras CI, Blattler T, Aguzzi A, Kopp N. New variant of Creutzfeldt-Jakob disease in a 26-year-old French man. Lancet 1996; 347: 1181.
164. Richard P, Renault F, Ostre E, Auzoux-Cheve M. Neurophysiological follow-up in two children with Creutzfeldt-Jakob disease after human growth hormone treatment. EEG Clin Neurophysiol 1994; 91: 100-7.
165. Vingerhoets FJG, Hegyi I, Aguzzi A, Myers P, Pizzolato G, Landis T. An unusual case of Creutzfeldt-Jakob disease. Neurology 1998; 51: 617-9.
166. Poursines Y, Boudouresques J, Roger J. Processus degeneratif atrophique diffus, a predominance thalamostriee. Semeiologie extra-pyramidale et psychique variable. Evolution subaigue a terminaison dementielle. Rev Neurol (Paris) 1953; 89: 266-71.
167. Tarkkanen A, Haltia M. Creutzfeldt-Jakob disease. Trans Ophthalmol Soc UK 1980; 100: 151-4.
168. Brunet P, Viader F, Henin D. Encephalopathie d'evolution rapide avec ophtalmoplegie supranucleaire et neuropathie peripherique. Rev Neurol (Paris) 1986; 142: 159-66.
169. Gomori AJ, Partnow MJ, Horoupian DS, Hirano A. The ataxic form of Creutzfeldt-Jakob disease. Arch Neurol 1973; 29: 318-23.
170. Landis DMD, Williams RS, Masters CL. Golgi and electronmicroscopic studies of spongiform encephalopathy. Neurology 1981; 31: 538-49.
171. Cochius JI, Hyman N, Esiri MM. Creutzfeldt-Jakob disease in a recipient of human pituitary-derived goandotrophin: a second case. J Neurol Neurosurg Psychiatry 1992; 55: 1094-5.
172. Hintz R, MacGillivray M, Joy A, Tintner R. Fatal degenerative neurological disease in patients who received pituitary-derived human growth hormone. MMWR 1985; 34: 359-66.
173. Billette de Villemeur R, Beauvais P, Gourmelen M, Richardet JM. Creutzfeldt-Jakob disease in children treated with growth hormone. Lancet 1991; 337: 864-5.
174. Billette de Villemeur T, Gourmelen M, Beauvais P, Maladie de Creutzfeldt-Jakob chez quatre enfants traites par hormone de croissance. Rev Neurol (Paris) 1992; 148: 328-34.
175. Marcus HS, Duchen LW, Parkin EM, Creutzfeldt-Jakob disease in recipients of human growth hormone in the United Kingdom: a clinical and radiographic study. Q J Med 1992; 82: 43-51.
176. Billette de Villemeur T, Gelot T, Deslys JP, Iatrogenic Creutzfeldt-Jakob disease in three growth hormone recipients: a neuropathological study. Neuropathol Appl Neurobiol 1994; 20: 111-7.
177. Shabtai H, Nisipeanu P, Chapman J, Korczyn AD. Pruritus in Creutzfeldt-Jakob disease. Neurology 1996; 46: 940-1.
178. Creange A, Gray F, Cesaro P, Creutzfeldt-Jakob disease after liver transplantation. Ann Neurol 1995; 38: 269-72.
179. Lugaresi E, Medori R, Montagna P, Fatal familial insomnia and dysautonomia with selective degeneration of thalamic nuclei. N Engl J Med 1986; 315: 997-1003.
180. Prusiner SB, Gajdusek DC, Alpers MP. Kuru with incubation periods exceeding two decades. Ann Neurol 1982; 12: 1-9.
181. Neetens A, Martin JJ. Neuro-ophthalmological aspects of prion diseases. Neuro-ophthalmology 1998; 19: 137-44.
182. Goldhammer Y, Bubis JJ, Sarova-Pinhas I, Braham J. Subacute spongiform encephalopathy and its relation to Jakob-Creutzfeldt disease: report on six cases. J Neurol Neurosurg Psychiatry 1972; 35: 1-10.
183. Rice GP A, Paty DW, Ball MJ, Tatham R, Kertesz A. Spongiform encephalopathy of long duration: a family study. Can J Neurol Sci 1980; 7: 171-6.
184. Raverdy P, Hauw JJ, Cathala F, Maladie de Creutzfeldt-Jakob ayant evolue 34 mois chez une femme de 26 ans. Rev Neurol (Paris) 1983; 139: 381-3.
185. Rother J, Schwartz A, Harle M, Wentz KU, Berlit P, Hennerici M. Magnetic resonance imaging follow-up in Creutzfeldt-Jakob disease. J Neurol 1992; 239: 404-6.
186. Bertoni JM, Brown P, Goldfarb LG, Rubenstein R, Gajdusek DC. Familial Creutzfeldt-Jakob disease (codon 200 mutation) with supranuclear palsy. JAMA 1992; 268: 2413-5.
187. Duchen LW, Poulter M, Harding AE. Dementia associated with a 216 base pair insertion in the prion protein gene: clinical and neuropathological features. Brain 1993; 116: 555-657.
188. Ross Russell RW. Supranuclear palsy of eyelid closure. Brain 1980; 103: 71-82.
189. Yokota T, Tsuchiya K, Yamane M, Hayashi M, Tanabe H, Tsukagoshi H. Geotropic ocular deviation with skew and absence of saccade in Creutzfeldt-Jacob disease. J Neurol Sci 1991; 106: 175-8.
190. Koch TK, Berg BO, De Armond SJ, Gravina RF. Creutzfeldt-Jakob disease in a young adult with idiopathic hypopituitarism: possible relation to the administration of cadaveric human growth hormone. N Engl J Med 1985; 313: 731-3.
191. Powell-Jackson J, Weller RO, Kennedy P, Preece MA, Whitcombe EM, Newsom-Davis J. Creutzfeldt-Jakob disease after administration of human growth hormone. Lancet 1985; II: 244-6.
192. Miyashita K, Inuzuka T, Kondo H, Creutzfeldt-Jakob disease in a patient with a cadaveric dural graft. Neurology 1991; 41: 940-1.
193. Tiegn GE, Drury I. Familial Creutzfeldt-Jakob disease without periodic EEG activity. Ann Neurol 1990; 28: 585-8.
194. Haltia M, Kovanen J, van Crevel H, Bots GTAM, Stefanko S. Familial Creutzfeldt-Jakob disease. J Neurol Sci 1979; 42: 381-9.
195. Cathala F, Chatelain J, Brown P, Dumas M, Gajdusek DC. Familial Creutzfeldt-Jakob disease: autosomal dominance in 14 members over 3 generations. J Neurol Sci 1980; 47: 343-51.
196. Gerstrnann J, Straussler E, Scheinker I. Ober eine eigenartige hereditar-familiare Erkrankung des Zentralnervensystems: zugleich ein Beitrag zur Frage des vorzeitigen lokalen Alterns. Z Ges Neurol Psych 1936; 154: 736-802.
197. Masters CL, Gajdusek DC, Gibbs CJ. Creutzfeldt-Jakob disease virus isolations from the Gerstrnann-Straussler syndrome with an analysis of the various forms of amyloid plaque deposition in the virus-induced spongiform encephalopathies. Brain 1981; 104: 559-88.
198. Farlow MR, Yee RD, Dlouhy SR, Conneally PM, Azzarelli B, Ghetti B. Gerstrnann-Straussler-Scheinker disease. I. Extending the clinical spectrum. Neurology 1989; 39: 1446-52.
199. Yee RD, Farlow MR, Suzuki DA, Betelak KF, Ghetti B. Abnormal eye movements in Gerstrnann-Straussler-Scheinker disease. Arch Ophthalmol 1992; 110: 68-74.
200. Kramer DW. Preseniele, subacute, progressieve encefalopathie met status myoclonicus. Ned Tijdschr Geneesk 1959; 103: 1662-1676.
201. Moussavian M, Potolicchio S, Jones R. The 14-3-3 brain protein and transmissible spongiform encephalopathy. N Engl J Med 1997; 336: 873-4.
202. Corbett JJ, Schatz NJ, Schults WT, Behrens M, Berry RG. Slowly alternating skew deviation: description of a pretectal syndrome in three patients. Ann Neurol 1981; 10: 540-565.
203. Bender MB. Polyopia and monocular diplopia of cerebral origin. Arch Neurol Psychiatry 1945; 54: 323-38.
204. Gaytan-Garcia S, Gilbert JJ, Kaufmann JCE. Jakob-Creutzfeldt disease associated with Wernicke encephalopathy. Can J Neurol Sci 1998; 15: 156-160.
205. Gajdusek DC, Zigas V. Degenerative disease of the central nervous system in New Guinea: the endemic occurrence of 'kuru' in the native population. N Engl J Med 1957; 257: 974-8.
206. Hornabrook RW. Kuru: subacute cerebellar degeneration. The natural history and clinical features. Brain 1968; 91: 53-74.
207. Brownell B, Oppenheimer DR. An ataxic form of subacute presenile polioencephalopathy (Creutzfeldt-Jakob disease). J Neurol Neurosurg Psychiatry 1965; 28: 350-461.
208. Jones HR, Hedley-White ET, Freidberg SR, Baker RA. Ataxic Creutzfeldt-Jakob disease: diagnostic techniques and neuropathologic observations in early disease. Neurology 1985; 35: 254-7.
209. Gibbs CJ, Joy A, Heffner R, Clinical and pathological features and laboratory confirmation of Creutzfeldt-Jakob disease in a recipient of pituitary-derived human growth hormone. N Engl J Med 1985; 313: 734-8.
210. Tintner R, Brown P, Hedley-White ET, Rappaport EB, Piccardo CP, Gajdusek DC. Neuropathologic verification of Creutzfeldt-Jakob disease in the exhumed American recipient of human pituitary growth hormone: epidemiologic and pathogenetic implications. Neurology 1986; 36: 932-943.
211. Marzewski DJ, Towfighi J, Harrington MG, Merril CR, Brown P. Creutzfeldt-Jakob disease following pituitaryderived human growth hormone therapy: a new American case. Neurology 1988; 38: 1131-3.
212. Brown P. Human growth hormone therapy and Creutzfeldt-Jakob disease: a drama in three acts. Pediatrics 1988; 81: 85-92.
213. Fradkin JE, Schonberger LB, Mills JL, Creutzfeldt-Jakob disease in pituitary growth hormone recipients in the United States. JAMA 1991; 265: 880-4.
214. Delisle MB, Fabre N, Rochiccioli P, Doerr-Schott J, Rumeau JL, Bes A. Maladie de Creutzfeldt-Jakob apres traitement par l'hormone de croissance extractive humaine: etude clinico-pathologique. Rev Neurol (Paris) 1993; 149: 524-7.
215. Holmes SJ, Ironside JW, Shalet SM. Neurosurgery in a patient with Creutzfeldt-Jakob disease after pituitary derived growth hormone therapy in childhood. J Neurol Neurosurg Psychiatry 1996; 60: 333-5.
216. Cochius JI, Mack K, Bums RJ, Alderman CP, Blumbergs PC. Creutzfeldt-Jakob disease in a recipient of human pituitaryderived gonadotrophin. Aust NZ J Med 1990; 20: 592-3.
217. Antoine JE, Michel D, Bertholon P, Creutzfeldt-Jakob disease after extracranial dura mater embolization for a nasopharyngeal angiofibroma. Neurology 1997; 48: 1451-3.
218. Goldhammer Y, Gabizon R, Meiner Z, Sadeh M. An Israeli family with Gerstrnann-Straussler-Scheinker disease manifesting the codon 102 mutation in the prion protein gene. Neurology 1993; 43: 2718-9.
219. Barbanti P, Fabbrini G, Salvatore M, Polymorphism at codon 129 or codon 219 of PRNP and clinical heterogeneity in a previously unreported family with Gerstrnann-Straussler-Scheinker disease (PrP-PI02L mutation). Neurology 1996; 47: 734-41.
220. Zieger A, Vonofakos D, Grafin Vitzthum H. Creutzfeldt-Jakobsche Krankheit: das Computertomogramm in Korrelation zu klinischen, elektroenzephalographischen und neuropathologischen Befunden. Nervenarzt 1981; 52: 685-91.
221. Westphal KP, Schachenmayr W. Computed tomography during Creutzfeldt-Jakob disease. Neuroradiology 1985; 27: 362-4.
222. Tobias E, Mann E, Bone I, De Silva R, Ironside J. A case of Creutzfeldt-Jakob disease presenting with cortical deafness. J Neurol Neurosurg Psychiatry 1994; 57: 872-3.
223. Helmchen C, Btittner U. Centripetal nystagmus in a case of Creutzfeldt-Jacob disease. Neuro-ophthalmology 1995; 15: 187-92.
224. Schoene WE, Masters CL, Gibbs CJ, Transmissible spongiform encephalopathy (Creutzfeldt-Jakob disease): atypical clinical and pathological findings. Arch Neurol 1981; 38: 473-7.
225. Haraguchi T, Akaura K, Yabuki S. Creutzfeldt-Jakob disease associated with ocular dipping: a case report. Rinsho Shinkeigaku-Clin Neurol 1998; 38: 70-73.
226. Bosque PJ, Vnencak-Jones CL, Johnson MD, Whitlock JA, McLean MJ. A PrP gene codon 178 base substitution and a 24-bp interstitial deletion in familial Creutzfeldt-Jakob disease. Neurology 1992; 42: 1864-70.
227. Spudis EV, Morris D. Ocular flutter. South Med J 1972; 65: 819-22.
228. Young K, Jones CK, Piccardo P, Gerstmann-Straussler-Scheinker disease with mutation at codon 102 and methionine at codon 129 of PRNP in previously unreported patients. Neurology 1995; 45: 1127-34.
229. van Gool WA, Hensels GW, Hoogerwaard EM, Wiezer JHA, Wesseling P, Bolhuis PA. Hypokinesia and presenile dementia in a Dutch family with a novel insertion in the prion protein gene. Brain 1995; 118: 1565-71.
230. Goldman S, Liard A, Flament-Durand J, Positron emission tomography and histopathology in Creutzfeldt-Jakob disease. Neurology 1993; 43: 1828-30.
231. Schwaninger M, Winter R, Hacke W, Magnetic resonance imaging in Creutzfeldt-Jakob disease: evidence of focal involvement of the cortex. J Neurol Neurosurg Psychiatry 1997; 63: 408-9.
232. Szirmai I, Guseo A, Czopf J, Palffy G. Analysis of clinical and electrophysiological findings in Jakob-Creutzfeldt disease. Arch Psychiatr Nervenk 1976; 222: 315-23.
233. Friedland RP, Prusiner SB, Jagust WI, Budinger TF, Davis RL. Bitemporal hypometabolism in Creutzfeldt-Jakob disease measured by positron emission tomography with [18Fl-2-fluorodeoxyglucose. J Comput Assist Tomogr 1984; 8: 978-81.
234. Aguglia U, Gambarelli D, Farnarier G, Quattrone A. Different susceptibilities of the geniculate and extrageniculate visual pathways to human Creutzfeldt-Jakob disease (a combined neurophysiologicalneuropathological study). Electroencephalogr Clin Neurophysiol 1991; 78: 413-23.
235. de Seze J, Hache JC, Vermersch P, Creutzfeldt-Jakob disease. Neurophysiologic visual impairments. Neurology 1998; 51: 962-7.
236. Gaches J, Supino-Viterbo V, Oughourlian JM. Unusual electroencephalographic and clinical evolution of a case of meningioma of the left temporo-occipital convexity. Eur Neurol 1971; 5: 155-64.
237. Barnett KC, Palmer AC. Retinopathy in sheep affected with natural scrapie. Res Vet Sci 1971; 12: 383-5.
238. Buyukmihci N, Marsh RF, Albert DM, Zelinski K. Ocular effects of scrapie agent in hamsters: preliminary observations. Invest Ophthalmol Vis Sci 1977; 16: 319-24.
239. Hogan RN, Baringer JR, Prusiner SB. Progressive retinal degeneration in scrapie-infected hamsters: a light and electron microscopic analysis. Lab Invest 1981; 44: 34-42.
240. Hogan RN, Kingsbury DT, Baringer JR, Prusiner SB. Retinal degeneration in experimental Creutzfeldt-Jakob disease. Lab Invest 1983; 49: 708-51.
241. Buyukmihci N, Goering-Harmon F, Marsh RF. Retinal degeneration in experimental scrapie after intraperitoneal or subcutaneous inoculation of hamsters. Exp Neurol 1985; 88: 461-6.
242. Hogan RN, Bowman KA, Baringer JR, Prusiner SB. Replication of scrapie prions in hamster eyes precedes retinal degeneration. Ophthalmic Res 1986; 18: 230-5.
243. Walis A, Liberski PP, Brown P, Gajdusek DC. Electron microscopic studies of the optic nerve in experimental scrapie and the panencephalopathic type of Creutzfeldt-Jakob disease. Fol Neuropathol 1997; 35: 255-8.
244. Kuritzky A, Davidovitch S, Sandbank U, Bechar M. Normal EEG in Creutzfeldt-Jakob disease. Neurology 1980; 30: 1134-5.